Related Experiment Video
Updated: Oct 26, 2025
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
Letter to the editor: radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers
Mateus Trinconi Cunha1, Vinicius Jardim Carvalho2, Rafael Maffei Loureiro3
1Medical Oncology, Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil mateustcunha@gmail.com.
Abstract:
A commentary on the original research article: 'Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers'. Of note, the predictor selection process, the cross-validation method, along with the lack of final testing of the developed model with a separated data set may mask overfitting, overestimating performance metrics.
